Gilead Sciences, Inc.
NASDAQ:GILD
83.94 (USD) • At close September 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Gilead Sciences, Inc. |
Symbool | GILD |
Munteenheid | USD |
Prijs | 83.94 |
Beurswaarde | 104,504,460,600 |
Dividendpercentage | 4.46% |
52-weken bereik | 62.07 - 87.87 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Daniel P. O'Day |
Website | https://www.gilead.com |
An error occurred while fetching data.
Over Gilead Sciences, Inc.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)